In addition, we discovered 13 B-ALL cases with aberrant GATA2 activation from 629 B-ALL patients, indicating that GATA2 dysregulation is a shared feature of different B-ALL subtypes. The gene discussed is GATA2; the disease is acute lymphoblastic leukemia.